Inactive Instrument

Highlights Venn Life Sciences Holdings London S.E.

Equities

HVIVO says Omicron contract validates move to Canary Wharf facility	06-03	AN
HVIVO plc Signs £2.5 Million Contract with A Mid-Sized Pharmaceutical Company to Initiate an Omicron characterization study	06-03	CI
HVIVO swings to profit and commences annual dividends as outlook rosy	04-09	AN
HVIVO plc Provides Revenue Guidance for the Year 2024	04-09	CI
HVIVO plc Reports Earnings Results for the Full Year Ended December 31, 2023	04-09	CI
European Green Transition starts trading on London's AIM market	04-08	AN
Investment firm European Green Transition plans listing on AIM	03-18	AN
HVIVO Chair and non-exec director sell 30.0 million shares	02-14	AN
HVIVO directors to sell total of 14 million shares	02-14	AN
Hvivo Shareholders Plan Secondary Placing to Sell 14 Million Shares	02-14	MT
HVIVO shares up after "record year" across all metrics	01-30	AN
Hvivo Wins GBP6 Million Antiviral Testing Contract	01-02	MT
HVIVO inks GBP6.3 million deal to test common cold treatment	01-02	AN
New Year begins largely green amid slew of PMIs	01-02	AN
HVIVO plc Signs £6.3 Million Human Challenge Study Model	01-02	CI
Hvivo Secures GBP17 Million Contract for RSV Antiviral Drug Testing; Stock Surges	12-13	MT
HVIVO signs deal to test RSV antiviral drug candidate with study model	12-13	AN
HVIVO interim profit jumps on revenue increase; ups full-year guidance	12/09/23	AN
UK Stocks-Factors to watch on Sept 12	12/09/23	RE
Earnings Flash (HVO.L) HVIVO Reports H1 Revenue GBP27.3M	12/09/23	MT

No results for this search